XML 38 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Assumptions Used to Calculate Fair Value of Options Granted to Employees and Directors

The assumptions used to estimate the fair value of options granted to employees and directors at the date of grant for the three and nine months ended September 30, 2014 were as follows:

 

    

Three months ended

September 30,

 

Nine months ended

September 30,

     2014   2013   2014   2013

Risk-free interest rate

   1.8-2.0%   1.9%   1.6-2.0%   0.1-1.9%

Expected dividend yield

   0%   0%   0%   0%

Expected term

   5.8-5.9 years   5.9 years   5.0-5.9 years   5.3-5.9 years

Expected volatility

   67-72%   67-68%   64-72%   67-68%

Schedule of Recognized Stock-Based Compensation Expense

The Company recognized stock-based compensation expense as follows for the three and nine months ended September 30, 2014 and 2013:

 

     Three months ended
September 30,
    Nine months ended
September 30,
 

(in thousands)

   2014      2013     2014      2013  

Employee awards:

          

Research and development

   $ 1,663       $ 1,517      $ 5,185       $ 4,453   

General and administrative

     1,143         1,212        4,596         3,609   
  

 

 

    

 

 

   

 

 

    

 

 

 

Stock-based compensation for employee awards

     2,806         2,729        9,781         8,062   

Stock-based compensation for non-employee awards

     44         (192     160         (109
  

 

 

    

 

 

   

 

 

    

 

 

 

Total stock-based compensation

   $ 2,850       $ 2,537      $ 9,941       $ 7,953   

Summary of Stock Option Activity

The following table summarizes stock option activity during the nine months ended September 30, 2014:

 

(in thousands, except per share amounts and years)

   Number
of
Shares
    Weighted
Average
Exercise Price
     Weighted
Average
Remaining
Contractual
Term
     Aggregate
Intrinsic
Value
 

Outstanding, December 31, 2013

     20,107      $ 3.93         6.11       $ 38,348   

Granted

     3,704      $ 5.45         

Exercised

     (2,793   $ 2.27         

Forfeited

     (471   $ 6.30         
  

 

 

   

 

 

    

 

 

    

 

 

 

Outstanding, September 30, 2014

     20,547      $ 4.37         6.38       $ 90,628   
  

 

 

   

 

 

    

 

 

    

 

 

 

Vested and expected to vest, September 30, 2014

     20,220      $ 4.35         6.33       $ 89,628   

Exercisable, September 30, 2014

     15,313      $ 3.84         5.50       $ 75,699